• Users Online: 199
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria

Dayananda Kiran K, Achur Rajeshwara N, Gowda D Channe

Year : 2018| Volume: 55| Issue : 1 | Page no: 1-8

   This article has been cited by
1 Plasmodium falciparum pre-erythrocytic stage vaccine development
Jessica Molina-Franky,Laura Cuy-Chaparro,Anny Camargo,César Reyes,Marcela Gómez,David Ricardo Salamanca,Manuel Alfonso Patarroyo,Manuel Elkin Patarroyo
Malaria Journal. 2020; 19(1)
[Pubmed]  [Google Scholar] [DOI]
2 Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin
Luann Wendel Pereira de Sena,Amanda Gabryelle Nunes Cardoso Mello,Michelle Valéria Dias Ferreira,Marcieni Andrade de Ataide,Rosa Maria Dias,José Luiz Fernandes Vieira
Malaria Journal. 2019; 18(1)
[Pubmed]  [Google Scholar] [DOI]
3 Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax
Karla Sena Guedes,Bruno Antônio Marinho Sanchez,Luciano Teixeira Gomes,Cor Jesus Fernandes Fontes,Leonardo Jose de Moura Carvalho
PLOS ONE. 2019; 14(11): e0224877
[Pubmed]  [Google Scholar] [DOI]
4 Cerebral malaria
Marta Valentim
Journal of Neurology & Stroke. 2018; 8(4)
[Pubmed]  [Google Scholar] [DOI]


Read this article